CLN5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.211000E-01
Normal-vs-Stage2
4.866200E-01
Normal-vs-Stage3
8.820400E-02
Normal-vs-Stage4
9.344000E-01
Stage1-vs-Stage2
1.964600E-01
Stage1-vs-Stage3
8.877100E-03
Stage1-vs-Stage4
6.453000E-01
Stage2-vs-Stage3
1.032580E-01
Stage2-vs-Stage4
4.742800E-01
Stage3-vs-Stage4
1.113660E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.110400E-01
Normal-vs-AfricanAmerican
4.039000E-01
Normal-vs-Asian
5.659200E-01
Caucasian-vs-AfricanAmerican
6.489200E-01
Caucasian-vs-Asian
8.476200E-01
AfricanAmerican-vs-Asian
8.204600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.334800E-01
Normal-vs-Female
5.614200E-01
Male-vs-Female
8.944200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.513200E-01
Normal-vs-Age(41-60Yrs)
8.593000E-01
Normal-vs-Age(61-80Yrs)
3.780800E-01
Normal-vs-Age(81-100Yrs)
6.114000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.742200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.996550E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.270000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.546390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.024200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.179600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.720800E-01
Normal-vs-Daily Drinker
2.331600E-01
Normal-vs-Weekly Drinker
1.306840E-01
Normal-vs-Occasional Drinker
9.200000E-01
Normal-vs-Social Drinker
7.830800E-01
Non Drinker-vs-Daily Drinker
9.726800E-01
Non Drinker-vs-Weekly Drinker
6.868200E-01
Non Drinker-vs-Occasional Drinker
3.458200E-02
Non Drinker-vs-Social Drinker
1.221580E-01
Daily Drinker-vs-Weekly Drinker
6.454000E-01
Daily Drinker-vs-Occasional Drinker
5.721600E-02
Daily Drinker-vs-Social Drinker
1.219790E-01
Weekly Drinker-vs-Occasional Drinker
2.994400E-02
Weekly Drinker-vs-Social Drinker
6.931900E-02
Occasional Drinker-vs-Social Drinker
5.471800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.869190E-01
Normal-vs-Grade 2
5.491900E-02
Normal-vs-Grade 3
1.042780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.765600E-01
Grade 1-vs-Grade 3
6.888000E-01
Grade 1-vs-Grade 4
1.869190E-01
Grade 2-vs-Grade 3
9.924800E-01
Grade 2-vs-Grade 4
5.491900E-02
Grade 3-vs-Grade 4
1.042780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.112000E-01
Normal-vs-NonDiabetic
5.602400E-01
Diabetic-vs-NonDiabetic
2.247600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.068600E-01
Normal-vs-NoPancreatitis
5.479400E-01
Pancreatitis-vs-NoPancreatitis
3.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.953800E-01
Normal-vs-N1
5.133800E-01
N0-vs-N1
8.497000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.858000E-01
Normal-vs-TP53-NonMutant
7.487200E-01
TP53-Mutant-vs-TP53-NonMutant
8.187200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
